Key result
Higher mWHO class during pregnancy is linked to progressively higher cardiac adverse event rates reaching ~51%.
Why the study?
To investigate the rate of obstetric and maternal outcomes in individuals with congenital or acquired cardiac disease according to the modified World Health Organization (mWHO) classification.
Does higher mWHO classification increase the risk of maternal, obstetric, and neonatal adverse outcomes in pregnant individuals with cardiac disease?
Meta-Analysis (n=95,400)
Does higher mWHO classification increase the risk of maternal, obstetric, and neonatal adverse outcomes in pregnant individuals with cardiac disease?
Answers are grounded in this paper and cite their sources.
The mWHO classification effectively stratifies not only maternal cardiovascular risk but also obstetric and neonatal outcomes, with mWHO IV pregnancies facing over 50% risk of cardiac adverse events and nearly 50% risk of NICU admission.
Objectives: To investigate the rate of obstetric and maternal outcomes in individuals with congenital or acquired cardiac disease according to the modified World Health Organization (mWHO) classification.Methods: This was a systematic review and meta-analysis.Medline, Cinahl, Cochrane Library and Scopus databases were searched electronically up to August 2025.We included prospective and retrospective studies on pregnancy outcomes in individuals with cardiac disease, reported according to the mWHO classification.Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale for cohort studies.A random-effects model with REML estimation was used to pool proportions, accounting for between-study heterogeneity.The study was registered with the PROSPERO database (CRD42024543896).Results: 32 studies were included in the meta-analysis, encompassing 95.400 pregnancies in indivisuals with cardiac disease.The rate of cardiac adverse event progressively increased from 2.9% (95% CI 1.5-4.4) in mWHO I to 50.8% (95% CI 40.9-60.7) in mWHO IV.Similar trends were observed for admission to ICU and maternal death, which reached 7.3% (95% CI 3.4-11.1)in mWHO IV.Among obstetric outcomes, the rates of hypertensive disorders were found higher in the lower-risk groups, decreasing from 10.6% (95% CI 6.1-15.0) in mWHO I, to 2.0% (95% CI 0.7-4.6) in mWHO IV.Other outcomes, including stillbirth, preterm birth and small for gestational age were more frequent in higher-risk groups.Similar trends were observed for neonatal outcomes, with higher rates of admission to neonatal intensive care unit in mWHO IV (47.8%, 95% CI 14.4-81.2) than in mWHO I (7.4%, 95% CI 2.9-11.9),and higher rates of congenital heart disease in the newborn (13.5%, 95% CI 4.3-22.7) in mWHO IV, compared to mWHO I (2.8%, 95% CI 0.7-6.3).Conclusions: Pregnancy in individuals with cardiac disease is associated with a high burden of maternal, obstetric, and neonatal complications that increases across mWHO classes.The mWHO classification identifies individuals at progressively higher risk of both cardiovascular and perinatal adverse outcomes, supporting its role in clinical risk stratification and counseling.
No takes yet. Share an insight, caveat, or question.
Sorrenti et al. (2026) conducted a meta-analysis in cardiac disease in pregnancy (n=95,400). mWHO class IV vs. mWHO class I was evaluated on cardiac adverse event. Pregnancy in individuals with cardiac disease was associated with cardiac adverse events that progressively increased from 2.9% in mWHO class I to 50.8% in mWHO class IV.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: